While this model is broadly applicable to any disease in which CD4+ T cells play a major role in the immune response, we focused our initial efforts on the use of the model to describe and predict the effects of potential therapeutic interventions in the context of C. difficile infection (CDI). The gene discussed is CD4; the disease is clostridium difficile infection.